Inovio Pharmaceuticals, Inc. (NASDAQ:INO – Get Rating) was the target of a significant growth in short interest during the month of April. As of April 15th, there was short interest totalling 39,650,000 shares, a growth of 13.9% from the March 31st total of 34,820,000 shares. Based on an average trading volume of 5,280,000 shares, the […]
Greenwich Wealth Management LLC lessened its holdings in shares of Inovio Pharmaceuticals, Inc. (NASDAQ:INO – Get Rating) by 39.9% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 18,700 shares of the biopharmaceutical company’s stock after selling 12,400 shares during the […]
Inovio Pharmaceuticals, Inc. (NASDAQ:INO – Get Rating) was the target of a significant decrease in short interest during the month of March. As of March 31st, there was short interest totalling 34,820,000 shares, a decrease of 11.9% from the March 15th total of 39,520,000 shares. Based on an average daily volume of 4,990,000 shares, the […]
Inovio Pharmaceuticals, Inc. (NASDAQ:INO – Get Rating) has earned an average recommendation of “Hold” from the six ratings firms that are currently covering the stock, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation and five have given a hold recommendation to the company. The average 1 year price objective among […]
Barclays PLC grew its position in Inovio Pharmaceuticals, Inc. (NASDAQ:INO – Get Rating) by 10,382.0% in the third quarter, according to its most recent filing with the SEC. The fund owned 1,156,481 shares of the biopharmaceutical company’s stock after acquiring an additional 1,145,448 shares during the period. Barclays PLC’s holdings in Inovio Pharmaceuticals were worth […]